CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Changjiang Runfa Medicine Co Ltd Company Snapshot
Changjiang Runfa Medicine Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Changjiang Runfa Medicine Co Ltd with three other companies in this sector in China: Zhejiang Jingxin Pharmaceutical Co., Ltd. (2016 sales of 1.87 billion Chinese Renmimbi [US$282.91 million] of which 57% was Pharmaceutical Ingredient), Shenzhen Hepalink Pharmaceutical Company Limited (2.26 billion Chinese Renmimbi [US$340.95 million] of which 100% was Pharmaceutical Manufacturing), and PKU HealthCare Corp Ltd (2.07 billion Chinese Renmimbi [US$312.35 million] of which 86% was Merchandise&Material Selling).

Sales Analysis. During the year ended December of 2016, sales at Changjiang Runfa Medicine Co Ltd were 2.11 billion Chinese Renmimbi (US$319.15 million). This is an increase of 98.6% versus 2015, when the company's sales were 1.06 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Changjiang Runfa Medicine Co Ltd
  Stock Performance Chart for Changjiang Runfa Medicine Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2017): 18.06
(Figures in Chinese Renmimbi)
1 Week -5.2%   13 Weeks -1.4%  
4 Weeks 10.1%   52 Weeks -14.4%  
 
Changjiang Runfa Medicine Co Ltd Key Data:
  Ticker: 002435 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 2,114,988,538
(Year Ending Jan 2017).
Employees: 1,939
  Currency: Chinese Renmimbi Market Cap: 8,863,428,918
  Fiscal Yr Ends: December Shares Outstanding: 490,776,795
  Share Type: A GU Closely Held Shares: 366,209,696
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.